Shanghai Shyndec Pharmaceutical (600420.SH): Ketamine Hydrochloride Injection obtained drug registration certificate.
GuoYaoXianDai (600420.SH) announcement, the company's wholly-owned subsidiary GuoYao Group Rongsheng Pharmaceutical Co., Ltd. (referred to as GuoYao Rongsheng) has received the "Drug Registration Certificate" issued by the National Medical Products Administration for ketocobalamin injection. The announcement shows that ketocobalamin injection is mainly used for peripheral artery disease (intermittent claudication or rest pain) and inner ear circulation disorders.
Shanghai Shyndec Pharmaceutical (600420.SH) announced that its wholly-owned subsidiary, China National Pharmaceutical Group Rongsheng Pharmaceutical Co., Ltd. (referred to as National Pharmaceutical Rongsheng), has received the "Drug Registration Certificate" issued by the National Medical Products Administration for the injection of ketoprofen. The announcement shows that ketoprofen injection is mainly used for: peripheral arterial diseases (intermittent claudication or rest pain); inner ear circulation disorders.
Related Articles
MNSO (09896) spent 1.9132 million Hong Kong dollars to repurchase 56,600 shares on March 3rd.
Angang Steel (00347) appoints He Yongya as its legal process agent.
XINYI SOLAR (00968) will distribute a final dividend of 0.8 Hong Kong cents per share on July 3rd.
MNSO (09896) spent 1.9132 million Hong Kong dollars to repurchase 56,600 shares on March 3rd.
Angang Steel (00347) appoints He Yongya as its legal process agent.
XINYI SOLAR (00968) will distribute a final dividend of 0.8 Hong Kong cents per share on July 3rd.
RECOMMEND
